Dialysis patients have extremely high premature death prices that are between 10 – and 100-fold greater than in the general population, and elevation exerts a significant quantifiable effect on dialysis patient survival, said study author Dr. Austin Stack in a journal news release. It really is an easily measured physical trait and our research demonstrates it is a significant prognostic marker for survival, said Stack, who is foundation chair of medication at the Graduate Entry Medical College at the University of Limerick, Ireland, and a consultant nephrologist at University Hospital Limerick. Dr. John Daugirdas, a nephrologist and medical professor at the University of Illinois, Chicago, wrote in an accompanying editorial that the findings are intriguing but at this point, it isn’t at all very clear what the physiology of increased mortality risk connected with taller stature may be, nor how this new understanding might affect clinical practice.‘It does look like safe, and we did discover evidence that resveratrol will get in to the brain,’ Turner said. Nevertheless, he added, ‘we’re not really prepared to recommend it as a treatment for Alzheimer’s.’ That’s not only because the research is ongoing: The product used in the analysis – – a synthetic, purified version of resveratrol – – isn’t available commercially. Resveratrol supplements have always been a staple in health food shops. But there is no telling how much of the substance, if any, is actually in those products, Turner pointed out.